Clinical Efficacy of Allergen-Specific Immunotherapy from Patient and Physician Perspectives.

ABSTRACT:

Purpose

Allergen-specific immunotherapy (AIT) is the only curative treatment for allergic diseases, but a few allergic patients receive AIT. In this multicenter cross-sectional study, we aimed to explore patient and physician perspectives on AIT through a questionnaire survey.

Materials and methods

Allergic patients who received subcutaneous immunotherapy for at least 1 year were asked to answer a questionnaire developed by an expert panel of allergen and immunotherapy workgroup in Korea.

Results

A total of 267 patients (adults, 60.3%) with allergic rhinitis (91.4%), asthma (42.7%), or atopic dermatitis (20.2%) from referred hospitals completed the survey. Among patients and physicians, respectively, the overall rates of satisfaction with AIT for allergic rhinitis wer

SUBMITTER: Shin YS 

PROVIDER: S-EPMC6479127 | biostudies-literature | 2019 May

REPOSITORIES: biostudies-literature